In a report released today, Kevin Steinke from Barrington maintained a Buy rating on Sharps Compliance (SMED – Research Report), with a price target of $6.00. The company’s shares closed last Monday at $3.24, close to its 52-week low of $2.91.
According to TipRanks.com, Steinke is a 5-star analyst with an average return of 11.1% and a 53.0% success rate. Steinke covers the Services sector, focusing on stocks such as Cross Country Healthcare, Heritage-Crystal Clean, and Heidrick & Struggles.
Sharps Compliance has an analyst consensus of Moderate Buy, with a price target consensus of $6.00.
Based on Sharps Compliance’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $17.58 million and GAAP net loss of $287K. In comparison, last year the company earned revenue of $27.53 million and had a net profit of $6.85 million.
Based on the recent corporate insider activity of 15 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of SMED in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Sharps Compliance Corp. engages in the provision of healthcare waste management services including medical, pharmaceutical, and hazardous. It focuses on developing management solutions for medical waste and unused dispensed medications generated by small and medium quantity generators. The company was founded in November 1992 and is headquartered in Houston, TX.
Read More on SMED:
- What Does the Website Traffic of Expedia, Booking Holdings, and Hyatt Indicate?
- Benchmark Co. Reaffirms Their Buy Rating on II-VI (IIVI)
- JetBlue Further Sweetens Its Bid for Spirit Airlines
- Why Did TD SYNNEX Stock Fall in Tuesday’s Pre-Market?
- Century Announces Filing of March 31, 2022 Year End Financial Results, Management Discussion and Analysis and Annual Information Form